10-Q 1 ggg-20220401.htm 10-Q ggg-20220401
April 1, 2022FALSE0000042888--12-30169,226,8472022Q116,86216,86200000428882022-01-012022-04-0100000428882022-04-14xbrli:sharesiso4217:USD00000428882020-12-262021-03-26iso4217:USDxbrli:shares00000428882022-04-0100000428882021-12-3100000428882020-12-2500000428882021-03-260000042888us-gaap:CommonStockMember2021-12-310000042888us-gaap:AdditionalPaidInCapitalMember2021-12-310000042888us-gaap:RetainedEarningsMember2021-12-310000042888us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310000042888us-gaap:CommonStockMember2022-01-012022-04-010000042888us-gaap:AdditionalPaidInCapitalMember2022-01-012022-04-010000042888us-gaap:RetainedEarningsMember2022-01-012022-04-010000042888us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-04-010000042888us-gaap:CommonStockMember2022-04-010000042888us-gaap:AdditionalPaidInCapitalMember2022-04-010000042888us-gaap:RetainedEarningsMember2022-04-010000042888us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-010000042888us-gaap:CommonStockMember2020-12-250000042888us-gaap:AdditionalPaidInCapitalMember2020-12-250000042888us-gaap:RetainedEarningsMember2020-12-250000042888us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-250000042888us-gaap:CommonStockMember2020-12-262021-03-260000042888us-gaap:AdditionalPaidInCapitalMember2020-12-262021-03-260000042888us-gaap:RetainedEarningsMember2020-12-262021-03-260000042888us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-262021-03-260000042888us-gaap:CommonStockMember2021-03-260000042888us-gaap:AdditionalPaidInCapitalMember2021-03-260000042888us-gaap:RetainedEarningsMember2021-03-260000042888us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-03-26ggg:segment0000042888ggg:IndustrialMemberus-gaap:OperatingSegmentsMember2022-01-012022-04-010000042888ggg:IndustrialMemberus-gaap:OperatingSegmentsMember2020-12-262021-03-260000042888ggg:ProcessMemberus-gaap:OperatingSegmentsMember2022-01-012022-04-010000042888ggg:ProcessMemberus-gaap:OperatingSegmentsMember2020-12-262021-03-260000042888ggg:ContractorMemberus-gaap:OperatingSegmentsMember2022-01-012022-04-010000042888ggg:ContractorMemberus-gaap:OperatingSegmentsMember2020-12-262021-03-260000042888us-gaap:CorporateNonSegmentMember2022-01-012022-04-010000042888us-gaap:CorporateNonSegmentMember2020-12-262021-03-260000042888ggg:IndustrialMemberus-gaap:OperatingSegmentsMember2022-04-010000042888ggg:IndustrialMemberus-gaap:OperatingSegmentsMember2021-12-310000042888ggg:ProcessMemberus-gaap:OperatingSegmentsMember2022-04-010000042888ggg:ProcessMemberus-gaap:OperatingSegmentsMember2021-12-310000042888ggg:ContractorMemberus-gaap:OperatingSegmentsMember2022-04-010000042888ggg:ContractorMemberus-gaap:OperatingSegmentsMember2021-12-310000042888us-gaap:CorporateNonSegmentMember2022-04-010000042888us-gaap:CorporateNonSegmentMember2021-12-310000042888country:US2022-01-012022-04-010000042888country:US2020-12-262021-03-260000042888us-gaap:NonUsMember2022-01-012022-04-010000042888us-gaap:NonUsMember2020-12-262021-03-260000042888country:US2022-04-010000042888country:US2021-12-310000042888us-gaap:NonUsMember2022-04-010000042888us-gaap:NonUsMember2021-12-310000042888us-gaap:EmployeeStockOptionMember2022-01-012022-04-010000042888us-gaap:EmployeeStockOptionMember2020-12-262021-03-26xbrli:pure0000042888us-gaap:EmployeeStockMember2022-01-012022-04-010000042888us-gaap:EmployeeStockMember2020-12-262021-03-260000042888us-gaap:PensionPlansDefinedBenefitMember2022-01-012022-04-010000042888us-gaap:PensionPlansDefinedBenefitMember2020-12-262021-03-260000042888us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-01-012022-04-010000042888us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-12-262021-03-260000042888us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-12-310000042888us-gaap:AccumulatedTranslationAdjustmentMember2021-12-310000042888us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-01-012022-04-010000042888us-gaap:AccumulatedTranslationAdjustmentMember2022-01-012022-04-010000042888us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-04-010000042888us-gaap:AccumulatedTranslationAdjustmentMember2022-04-010000042888us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-12-250000042888us-gaap:AccumulatedTranslationAdjustmentMember2020-12-250000042888us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-12-262021-03-260000042888us-gaap:AccumulatedTranslationAdjustmentMember2020-12-262021-03-260000042888us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-03-260000042888us-gaap:AccumulatedTranslationAdjustmentMember2021-03-260000042888us-gaap:CustomerRelationshipsMember2022-04-010000042888ggg:PatentsProprietaryTechnologyAndProductDocumentationMember2022-04-010000042888us-gaap:TrademarksAndTradeNamesMember2022-04-010000042888us-gaap:TradeNamesMember2022-04-010000042888us-gaap:CustomerRelationshipsMember2022-01-012022-04-010000042888ggg:PatentsProprietaryTechnologyAndProductDocumentationMember2022-01-012022-04-010000042888us-gaap:TrademarksAndTradeNamesMember2022-01-012022-04-010000042888us-gaap:TradeNamesMember2022-01-012022-04-010000042888us-gaap:CustomerRelationshipsMember2021-12-310000042888ggg:PatentsProprietaryTechnologyAndProductDocumentationMember2021-12-310000042888us-gaap:TrademarksAndTradeNamesMember2021-12-310000042888us-gaap:TradeNamesMember2021-12-310000042888us-gaap:CustomerRelationshipsMember2020-12-262021-12-310000042888ggg:PatentsProprietaryTechnologyAndProductDocumentationMember2020-12-262021-12-310000042888us-gaap:TrademarksAndTradeNamesMember2020-12-262021-12-310000042888us-gaap:TradeNamesMember2020-12-262021-12-3100000428882020-12-262021-12-310000042888ggg:IndustrialMember2021-12-310000042888ggg:ProcessMember2021-12-310000042888ggg:ContractorMember2021-12-310000042888ggg:IndustrialMember2022-01-012022-04-010000042888ggg:ProcessMember2022-01-012022-04-010000042888ggg:ContractorMember2022-01-012022-04-010000042888ggg:IndustrialMember2022-04-010000042888ggg:ProcessMember2022-04-010000042888ggg:ContractorMember2022-04-010000042888us-gaap:FairValueInputsLevel2Member2022-04-010000042888us-gaap:FairValueInputsLevel2Member2021-12-310000042888us-gaap:FairValueInputsLevel3Member2022-04-010000042888us-gaap:FairValueInputsLevel3Member2021-12-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

Quarterly Report Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934
For the quarterly period ended April 1, 2022

Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from to

Commission File Number:  001-09249
GRACO INC.
(Exact name of registrant as specified in its charter)     
 
Minnesota41-0285640
(State or other jurisdiction of incorporation or organization)  (I.R.S. Employer Identification Number)     
 
88 - 11th Avenue N.E.
Minneapolis,Minnesota55413
(Address of principal executive offices)    (Zip Code)     
(612)623-6000
(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $1.00 per shareGGGThe New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
YesNo
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
YesNo
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filerAccelerated filerNon-accelerated filerSmaller reporting company
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
YesNo

169,226,847 shares of the Registrant’s Common Stock, $1.00 par value, were outstanding as of April 14, 2022.



TABLE OF CONTENTS 
2

PART I     Item 1.
GRACO INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF EARNINGS
(Unaudited) (In thousands except per share amounts)
 Three Months Ended
 April 1,
2022
March 26,
2021
Net Sales$494,285 $454,129 
Cost of products sold239,810 206,795 
Gross Profit254,475 247,334 
Product development19,078 19,571 
Selling, marketing and distribution62,995 62,228 
General and administrative44,039 37,249 
Operating Earnings128,363 128,286 
Interest expense5,287 2,428 
Other expense, net153 121 
Earnings Before Income Taxes122,923 125,737 
Income taxes22,080 20,050 
Net Earnings$100,843 $105,687 
Net Earnings per Common Share
Basic
$0.59 $0.63 
Diluted
$0.58 $0.61 
See notes to consolidated financial statements.


CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Unaudited) (In thousands)
 Three Months Ended
 April 1,
2022
March 26,
2021
Net Earnings$100,843 $105,687 
Components of other comprehensive
income (loss)
Cumulative translation adjustment
(2,960)(10,470)
Pension and postretirement medical
liability adjustment
894 3,308 
Income taxes - pension and postretirement
medical liability adjustment
(194)(672)
Other comprehensive income (loss)(2,260)(7,834)
Comprehensive Income$98,583 $97,853 
See notes to consolidated financial statements.
3

GRACO INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(Unaudited) (In thousands)
April 1,
2022
December 31,
2021
ASSETS
Current Assets
Cash and cash equivalents$380,487 $624,302 
Accounts receivable, less allowances of $7,200 and $3,900
339,407 325,132 
Inventories436,741 382,301 
Other current assets40,585 31,886 
Total current assets1,197,220 1,363,621 
Property, Plant and Equipment, net487,805 451,061 
Goodwill371,401 356,255 
Other Intangible Assets, net154,006 149,740 
Operating Lease Assets31,228 30,046 
Deferred Income Taxes42,195 55,786 
Other Assets35,590 36,689 
Total Assets$2,319,445 $2,443,198 
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current Liabilities
Notes payable to banks$40,160 $43,489 
Current portion of long term debt 75,000 
Trade accounts payable88,108 78,432 
Salaries and incentives47,809 82,941 
Dividends payable35,678 35,771 
Other current liabilities190,558 191,159 
Total current liabilities402,313 506,792 
Long-term Debt75,000 75,000 
Retirement Benefits and Deferred Compensation105,129 106,897 
Operating Lease Liabilities24,209 23,527 
Deferred Income Taxes10,193 10,661 
Other Non-current Liabilities12,345 10,978 
Shareholders’ Equity
Common stock169,223 170,308 
Additional paid-in-capital761,959 742,288 
Retained earnings841,503 876,916 
Accumulated other comprehensive income (loss)(82,429)(80,169)
Total shareholders’ equity1,690,256 1,709,343 
Total Liabilities and Shareholders’ Equity$2,319,445 $2,443,198 
See notes to consolidated financial statements.
4

GRACO INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited) (In thousands)
 Three Months Ended
 April 1,
2022
March 26,
2021
Cash Flows From Operating Activities
Net Earnings$100,843 $105,687 
Adjustments to reconcile net earnings to net cash
provided by operating activities
Depreciation and amortization15,570 14,515 
Deferred income taxes10,973 1,842 
Share-based compensation7,088 6,618 
Change in
Accounts receivable(14,296)(10,611)
Inventories(52,979)(27,541)
Trade accounts payable9,216 9,323 
Salaries and incentives(35,341)(6,949)
Retirement benefits and deferred compensation(136)2,867 
Other accrued liabilities(8,690)4,493 
Other(923)1,425 
Net cash provided by operating activities31,325 101,669 
Cash Flows From Investing Activities
Property, plant and equipment additions(47,093)(21,415)
Acquisition of businesses, net of cash acquired(25,016) 
Other(134)(34)
Net cash used in investing activities(72,243)(21,449)
Cash Flows From Financing Activities
Borrowings on short-term lines of credit, net(3,420)9,667 
Payments on long-term debt(75,000) 
Payments of debt issuance costs (1,404)
Common stock issued21,294 26,460 
Common stock repurchased(108,706) 
Taxes paid related to net share settlement of equity awards(1,219) 
Cash dividends paid(35,801)(31,642)
Net cash used in financing activities(202,852)3,081 
Effect of exchange rate changes on cash(45)(1,594)
Net increase in cash and cash equivalents(243,815)81,707 
Cash and Cash Equivalents
Beginning of year624,302 378,909 
End of period$380,487 $460,616 
See notes to consolidated financial statements.
5

GRACO INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY
(Unaudited) (In thousands)
Common
Stock
Additional
Paid-In
Capital
Retained
Earnings
Accumulated
Other
Comprehensive
Income (Loss)
Total
Three Months Ended April 1, 2022
Balance, December 31, 2021$170,308 $742,288 $876,916 $(80,169)$1,709,343 
Shares issued437 19,638 20,075 
Shares repurchased(1,522)(6,636)(100,548)(108,706)
Stock compensation cost6,670 6,670 
Restricted stock canceled (issued)(1)(1)
Net earnings100,843 100,843 
Dividends declared ($0.210 per share)
(35,708)(35,708)
Other comprehensive income (loss)(2,260)(2,260)
Balance, April 1, 2022$169,223 $761,959 $841,503 $(82,429)$1,690,256 


Three Months Ended March 26, 2021
Balance, December 25, 2020$168,568 $671,206 $568,295 $(124,165)$1,283,904 
Shares issued845 25,615   26,460 
Stock compensation cost 6,008   6,008 
Net earnings  105,687  105,687 
Dividends declared ($0.188 per share)
  (31,723) (31,723)
Other comprehensive income (loss)   (7,834)(7,834)
Balance, March 26, 2021$169,413 $702,829 $642,259 $(131,999)$1,382,502 



See notes to consolidated financial statements.
6

GRACO INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
1.Basis of Presentation

The consolidated balance sheet of Graco Inc. and subsidiaries (the “Company”) as of April 1, 2022 and the related statements of earnings, comprehensive income and shareholders' equity for the three months ended April 1, 2022 and March 26, 2021, and cash flows for the three months ended April 1, 2022 and March 26, 2021 have been prepared by the Company and have not been audited.

In the opinion of management, these consolidated financial statements reflect all adjustments (consisting of only normal recurring adjustments) necessary to present fairly the financial position of the Company as of April 1, 2022, and the results of operations and cash flows for all periods presented.

Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted. Therefore, these statements should be read in conjunction with the financial statements and notes thereto included in the Company’s 2021 Annual Report on Form 10-K.

The results of operations for interim periods are not necessarily indicative of results that will be realized for the full fiscal year.

2.Segment Information

Effective January 1, 2022, our high performance coatings and foam product offerings previously included within the Applied Fluid Technologies division of the Industrial segment were realigned and are now managed under the Contractor segment. This change aligns the types of products offered and markets served within the segments. Prior year segment information has been restated to conform to the current organizational structure.

The Company has three reportable segments: Industrial, Process and Contractor. Sales and operating earnings by segment were as follows (in thousands): 
 Three Months Ended
 April 1,
2022
March 26,
2021
Net Sales
 Industrial$144,669 $129,864 
 Process115,024 91,373 
 Contractor234,592 232,892 
 Total$494,285 $454,129 
Operating Earnings
 Industrial$52,630 $42,358 
 Process27,488 21,733 
 Contractor58,947 71,051 
 Unallocated corporate (expense)(10,702)(6,856)
 Total$128,363 $128,286 

7

Assets by segment were as follows (in thousands): 
April 1,
2022
December 31,
2021
Industrial
$601,377 $601,843 
Process
497,363 436,203 
Contractor
614,150 599,726 
Unallocated corporate
606,555 805,426 
Total
$2,319,445 $2,443,198 

Geographic information follows (in thousands):
 Three Months Ended
 April 1,
2022
March 26,
2021
Net Sales (based on customer location)
United States
$255,082 $231,501 
Other countries
239,203 222,628 
Total
$494,285 $454,129 

 April 1,
2022
December 31,
2021
Long-lived Assets
United States
$425,657 $388,835 
Other countries
62,148 62,226 
Total
$487,805 $451,061 


3.Earnings per Share

The following table sets forth the computation of basic and diluted earnings per share (in thousands, except per share amounts):
 Three Months Ended
 April 1,
2022
March 26,
2021
Net earnings available to common shareholders
$100,843 $105,687 
Weighted average shares outstanding for basic earnings per share169,809 168,948 
Dilutive effect of stock options computed using the treasury stock method and the average market price4,869 4,900 
Weighted average shares outstanding for diluted earnings per share174,678 173,848 
Basic earnings per share
$0.59 $0.63 
Diluted earnings per share
$0.58 $0.61 

Stock options to purchase 1,250,000 and 700,000 shares were not included in the April 1, 2022 and March 26, 2021 computations of diluted earnings per share, respectively, because they would have been anti-dilutive.

8

4.Share-Based Awards

Options on common shares granted and outstanding, as well as the weighted average exercise price, are shown below (in thousands, except exercise prices):
Option
Shares
Weighted Average
Exercise Price
Options
Exercisable
Weighted Average
Exercise Price
Outstanding, December 31, 20219,575 $39.31 7,296 $33.75 
Granted831 71.73 
Exercised(162)22.90 
Canceled(19)43.06 
Outstanding, April 1, 202210,225 $42.20 7,751 $35.67 

The Company recognized year-to-date share-based compensation of $7.1 million in 2022 and $6.6 million in 2021. As of April 1, 2022, there was $18.4 million of unrecognized compensation cost related to unvested options, expected to be recognized over a weighted average period of 3.3 years.

The fair value of each option grant is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions and results:
 Three Months Ended
 April 1,
2022
March 26,
2021
Expected life in years
7.37.5
Interest rate
1.9 %0.9 %
Volatility
25.5 %25.2 %
Dividend yield
1.2 %1.0 %
Weighted average fair value per share
$19.06 $17.66 

Under the Company’s Employee Stock Purchase Plan, the Company issued 298,000 shares in 2022 and 416,000 shares in 2021. The fair value of the employees’ purchase rights under this Plan was estimated on the date of grant. The benefit of the 15 percent discount from the lesser of the fair market value per common share on the first day and the last day of the plan year was added to the fair value of the employees’ purchase rights determined using the Black-Scholes option-pricing model with the following assumptions and results:
 Three Months Ended
 April 1,
2022
March 26,
2021
Expected life in years
1.01.0
Interest rate
0.9 %0.1 %
Volatility
20.5 %40.1 %
Dividend yield
1.2 %1.1 %
Weighted average fair value per share
$16.01 $21.50 

9

5.Retirement Benefits

The components of net periodic benefit cost for retirement benefit plans were as follows (in thousands):
 Three Months Ended
 April 1,
2022
March 26,
2021
Pension Benefits
Service cost
$2,170 $2,721 
Interest cost
2,738 2,981 
Expected return on assets
(4,802)(5,130)
Amortization and other
1,076 2,551 
Net periodic benefit cost
$1,182 $3,123 
Postretirement Medical
Service cost
$175 $175 
Interest cost
225 250 
Amortization
175 250 
Net periodic benefit cost
$575 $675 

6.Shareholders’ Equity

Changes in components of accumulated other comprehensive income (loss), net of tax were as follows (in thousands):
Pension and
Postretirement
Medical
Cumulative
Translation
Adjustment
Total
Three Months Ended April 1, 2022
Balance, December 31, 2021$(60,107)$(20,062)$(80,169)
Other comprehensive income (loss) before reclassifications (2,960)(2,960)
Reclassified to pension cost and deferred tax700  700 
Balance, April 1, 2022$(59,407)$(23,022)$(82,429)

Three Months Ended March 26, 2021
Balance, December 25, 2020$(114,129)$(10,036)$(124,165)
Other comprehensive income (loss) before reclassifications (10,470)(10,470)
Reclassified to pension cost and deferred tax2,636  2,636 
Balance, March 26, 2021$(111,493)$(20,506)$(131,999)

Amounts related to pension and postretirement medical adjustments are reclassified to non-service components of pension cost that are included within other non-operating expenses.


10


7.Receivables and Credit Losses

Accounts receivable includes trade receivables of $330 million and other receivables of $9 million as of April 1, 2022 and $315 million and $10 million, respectively, as of December 31, 2021.

Allowance for Credit Losses

Following is a summary of activity in the year to date allowance for credit losses (in thousands):
April 1,
2022
March 26,
2021
Balance, beginning$3,254 $3,745 
Additions (reversals) charged to costs and expenses3,220 158 
Deductions from reserves (1)
(33)(104)
Other additions (deductions) (2)
33 (75)
Balance, ending$6,474 $3,724 

(1)    Represents amounts determined to be uncollectible and charged against reserves, net of collections on accounts previously charged against reserves.
(2) Includes amounts assumed or established in connection with acquisitions and effects of foreign currency translation.


8.Inventories

Major components of inventories were as follows (in thousands):
April 1,
2022
December 31,
2021
Finished products and components$194,563 $166,922 
Products and components in various stages of completion126,214 117,063 
Raw materials and purchased components205,893 185,291 
Subtotal526,670 469,276 
Reduction to LIFO cost(89,929)(86,975)
Total$436,741 $382,301 

11

9.Intangible Assets

Components of other intangible assets were as follows (dollars in thousands):
Finite LifeIndefinite Life
Customer
Relationships
Patents and
Proprietary
Technology
Trademarks,
Trade Names
and Other
Trade
Names
Total
As of April 1, 2022
Cost
$202,903 $26,974 $1,700 $62,633 $294,210 
Accumulated amortization
(112,499)(16,454)(503)— (129,456)
Foreign currency translation(8,410)(761) (1,577)(10,748)
Book value
$81,994 $9,759 $1,197 $61,056 $154,006 
Weighted average life in years
13105N/A
As of December 31, 2021
Cost
$194,505 $26,074 $900 $62,633 $284,112 
Accumulated amortization
(108,657)(15,734)(452)— (124,843)
Foreign currency translation(7,710)(707) (1,112)(9,529)
Book value
$78,138 $9,633 $448 $61,521 $149,740 
Weighted average life in years
13105N/A

Amortization of intangibles for the quarter was $4.6 million in 2022 and $4.3 million in 2021. Estimated annual amortization expense based on the current carrying amount of other intangible assets is as follows (in thousands):
2022 (Remainder)2023202420252026Thereafter
Estimated Amortization Expense$14,503 $17,776 $16,533 $15,967 $9,155 $19,016 

Changes in the carrying amount of goodwill for each reportable segment were as follows (in thousands): 
Industrial    Process    Contractor    Total    
Balance, December 31, 2021$185,733 $141,304 $29,218 $356,255 
Additions, adjustments from business acquisitions 16,862  16,862 
Foreign currency translation(1,246)(470) (1,716)
Balance, April 1, 2022$184,487 $157,696 $29,218 $371,401 

In the first quarter the Company completed the acquisition of a business that is not material to the consolidated financial statements.



12

10.Other Current Liabilities
Components of other current liabilities were as follows (in thousands):
April 1,
2022
December 31,
2021
Accrued self-insurance retentions
$11,576 $9,303 
Accrued warranty and service liabilities
14,560 14,463 
Accrued trade promotions
10,141 15,872 
Payable for employee stock purchases
3,921 15,746 
Customer advances and deferred revenue
66,668 60,554 
Income taxes payable
12,481 5,200 
Right of return refund liability18,713 18,614 
Operating lease liabilities, current 9,449 9,096 
Other
43,049 42,311 
Total
$190,558 $191,159 

A liability is established for estimated future warranty and service claims that relate to current and prior period sales. The Company estimates warranty costs based on historical claim experience and other factors including evaluating specific product warranty issues. Following is a summary of activity in accrued warranty and service liabilities (in thousands):
Balance, December 31, 2021$14,463 
Assumed in business acquisition38 
Charged to expense2,043 
Margin on parts sales reversed791 
Reductions for claims settled(2,775)
Balance, April 1, 2022$14,560 

Deferred Revenue

Revenue is deferred when cash payments are received or due in advance of performance, including amounts which are refundable. This is also the case for services associated with certain product sales. The balance in the deferred revenue and customer advances was $66.7 million as of April 1, 2022 and $60.6 million as of December 31, 2021. Net sales for the year to date included $22.5 million in 2022 and $40.9 million in 2021 that related to deferred revenue as of the beginning of each period.

11.Fair Value

Assets and liabilities measured at fair value on a recurring basis and fair value measurement level were as follows (in thousands):
Level   April 1,
2022
December 31,
2021
Assets
Cash surrender value of life insurance2$22,052 $23,147 
Liabilities
Contingent consideration3$15,924 $12,274 
Deferred compensation25,795 5,962 
Forward exchange contracts2173 111 
Total liabilities at fair value$21,892 $18,347 

Contracts insuring the lives of certain employees who are eligible to participate in certain non-qualified pension and deferred compensation plans are held in trust. Cash surrender value of the contracts is based on performance measurement funds that shadow the deferral investment allocations made by participants in certain deferred
13

compensation plans. The deferred compensation liability balances are valued based on amounts allocated by participants to the underlying performance measurement funds.

Contingent consideration liability represents the estimated value (using a probability-weighted expected return approach) of future payments to be made to previous owners of certain acquired businesses based on future revenues.

Long-term notes payable with fixed interest rates had a carrying amount of $75 million and estimated fair value of $80 million as of April 1, 2022. As of December 31, 2021, the long- term notes had a carrying amount of $150 million and estimated fair value of $165 million. The fair value of variable rate borrowings approximates carrying value. The Company uses significant other observable inputs to estimate fair value (level 2 of the fair value hierarchy) based on the present value of future cash flows and rates that would be available for issuance of debt with similar terms and remaining maturities.

14

Item 2. GRACO INC. AND SUBSIDIARIES

MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Overview

The Company supplies technology and expertise for the management of fluids and coatings in both industrial and commercial applications. It designs, manufactures and markets systems and equipment to move, measure, control, dispense and spray fluid and coating materials. Management classifies the Company’s business into three reportable segments: Industrial, Process and Contractor. Key strategies include developing and marketing new products, leveraging products and technologies into additional, growing end-user markets, expanding distribution globally and completing strategic acquisitions that provide additional channel and technologies.

The ongoing global COVID-19 pandemic and related governmental, business and societal responses continue to have an impact on our operations, supply chains, distribution channels, and end-user customers. The timing, duration, and extent of the impact from the pandemic in our major geographies is still uncertain and we cannot predict the magnitude of the impact to the results of our operations or financial position.

The Company continues to experience logistical and production constraints associated with raw materials and purchased components. These constraints were due to limited raw material and component availability, reduced freight capacity, shipping delays, and labor shortages as a result of responses to the COVID-19 pandemic and other supply chain disruptions. We also experienced the effects of price inflation related to raw materials, purchased components, and freight and transportation costs. The supply chain disruptions and associated effects of inflation have adversely impacted profitability in the near-term and limited our ability to satisfy strengthening customer demand, especially within our high-volume Contractor segment. We expect these challenges to continue into at least the first half of 2022.

The Company also has historically sold products to customers located in or associated with Russia and Belarus. In response to Russia's invasion of Ukraine, the United States, the United Kingdom, the European Union, Switzerland and others have initiated sanctions and export controls targeting Russia and Belarus and entities associated with those countries, which significantly limits our ability to sell certain products, serve certain customers and collect on our outstanding receivables. As a result, we have decided to suspend sales into Russian and Belarus for the time being. Sales to Russia and Belarus accounted for approximately 1.5% of our 2021 net sales and were not material for the first quarter of 2022.

The duration and extent to which the pandemic and trade sanctions against Russia and Belarus affect the Company's business will depend on future developments which still remain uncertain.

The following Management’s Discussion and Analysis reviews significant factors affecting the Company’s results of operations and financial condition. This discussion should be read in conjunction with the financial statements and the accompanying notes to the financial statements.

Consolidated Results

A summary of financial results follows (in millions except per share amounts):
 Three Months Ended
 Apr 1,
2022
Mar 26,
2021
%
 Change 
Net Sales
$494.3 $454.1 %
Operating Earnings
128.4 128.3 — %
Net Earnings
100.8 105.7 (5)%
Net Earnings, adjusted (1)
99.3 101.6 (2)%
Diluted Net Earnings per Common Share
$0.58 $0.61 (5)%
Diluted Net Earnings per Common Share, adjusted (1)
$0.57 $0.58 (2)%
(1) See below for a reconciliation of adjusted non-GAAP financial measures to GAAP.
15


Sales increased 9 percent compared to last year led by double-digit growth in the Industrial and Process segments. Changes in currency translation rates reduced worldwide sales by $7 million (2 percentage points). Sales from acquired operations contributed approximately $2 million (1 percentage point).
Gross profit margin rate for the quarter weakened mainly due to higher product costs.Total operating expenses for the quarter increased $7 million (6 percent) compared to prior year. Operating expenses as a percentage of sales decreased approximately one percentage point compared to prior year.
Excluding the impact of excess tax benefits related to stock option exercises presents a more consistent basis for comparison of financial results. A calculation of the non-GAAP measurements of adjusted income taxes, effective income tax rates, net earnings and diluted earnings per share follows (in millions except per share amounts):
Three Months Ended
April 1,
2022
March 26,
2021
Earnings before income taxes$122.9 $125.7 
Income taxes, as reported$22.1 $20.0 
Excess tax benefit from option exercises1.5 4.1 
Income taxes, adjusted$23.6 $24.1 
Effective income tax rate
   As reported18.0 %15.9 %
   Adjusted19.2 %19.2 %
Net Earnings, as reported$100.8 $105.7 
Excess tax benefit from option exercises(1.5)(4.1)
Net Earnings, adjusted$99.3 $101.6 
Weighted Average Diluted Shares174.7 173.8 
Diluted Earnings per Share
   As reported$0.58 $0.61 
   Adjusted$0.57 $0.58 

The following table presents an overview of components of net earnings as a percentage of net sales:
Three Months Ended
April 1,
2022
March 26,
2021
Net Sales100.0 %100.0 %
Cost of products sold48.5 45.5 
Gross Profit51.5 54.5 
Product development3.9 4.3 
Selling, marketing and distribution12.7 13.7 
General and administrative8.9 8.2 
Operating Earnings26.0 28.2 
Interest expense1.1 0.5 
Other expense, net— — 
Earnings Before Income Taxes24.9 27.7 
Income taxes4.5 4.4 
Net Earnings20.4 %23.3 %

16

Net Sales

The following table presents net sales by geographic region (in millions):
 Three Months Ended
 April 1,
2022
March 26,
2021
Americas(1)
$293.2 $264.9 
EMEA(2)
106.2 110.2 
Asia Pacific94.9 79.0 
Consolidated$494.3 $454.1 
(1)     North, South and Central America, including the United States
(2)    Europe, Middle East and Africa

The following table presents the components of net sales change by geographic region:
Three Months
Volume and PriceAcquisitions CurrencyTotal
Americas11%0%0%11%
EMEA0%2%(6)%(4)%
Asia Pacific22%0%(2)%20%
Consolidated10%1%(2)%9%

Gross Profit

Gross profit margin rate decreased 3 percentage points compared to last year. Realized pricing was unable to offset higher product costs caused by ongoing supply chain and inflationary challenges and the adverse impacts of changes in currency translation rates. The full impact of price changes implemented in the first quarter will be realized as the year progresses.

Operating Expenses

Total operating expenses for the quarter increased $7 million (6 percent) compared to last year. The increase includes $3 million (3 percentage points) of allowances for credit losses on customer receivables in Russia and Belarus. Operating expenses expressed as a percentage of sales decreased approximately one percentage point compared to last year.

Other Expense

Other non-operating expenses increased $3 million for the quarter due to interest expense which included a $3.5 million fee related to the prepayment of private placement debt.
Income Taxes

The effective income tax rate for the quarter was 18 percent, up 2 percentage points from the prior year quarter. The increase in the effective tax rate was primarily due to decreases in excess tax benefits for stock option exercises.


17

Segment Results

Certain measurements of segment operations compared to last year are summarized below:

Industrial Segment

The following table presents net sales and operating earnings as a percentage of sales for the Industrial segment
(dollars in millions):
 Three Months Ended
 April 1,
2022
March 26,
2021
Net Sales
Americas
$54.3 $46.3 
EMEA
47.9 45.1 
Asia Pacific
42.5 38.5 
Total
$144.7 $129.9 
Operating earnings as a percentage of net sales
36 %33 %

The following table presents the components of net sales change by geographic region for the Industrial segment:
Three Months
Volume and PriceAcquisitions CurrencyTotal
Americas17%0%0%17%
EMEA13%0%(7)%6%
Asia Pacific11%0%0%11%
Segment Total14%0%(3)%11%

Continued economic strength in the Americas, project activity in EMEA and increased economic activity in Asia Pacific contributed to the increase in Industrial segment sales. The operating margin rate increased 3 percentage points as realized pricing and expense leverage more than offset higher product costs and the adverse impacts of currency translation.

Process Segment

The following table presents net sales and operating earnings as a percentage of sales for the Process segment
(dollars in millions):
 Three Months Ended
 April 1,
2022
March 26,
2021
Net Sales
Americas
$68.4 $56.8 
EMEA
17.1 14.8 
Asia Pacific
29.5 19.8 
Total
$115.0 $91.4 
Operating earnings as a percentage of net sales
24 %24 %

18

The following table presents the components of net sales change by geographic region for the Process segment:
Three Months
Volume and PriceAcquisitions CurrencyTotal
Americas20%0%0%20%
EMEA19%0%(3)%16%
Asia Pacific51%0%(2)%49%
Segment Total26%0%0%26%

The Process segment had sales growth in all product applications. The operating margin rate for this segment was flat compared to last year. Expense leverage offset higher product costs, unfavorable product and channel mix and the adverse impacts of currency translation.

Contractor Segment

The following table presents net sales and operating earnings as a percentage of sales for the Contractor segment
(dollars in millions):
 Three Months Ended
 April 1,
2022
March 26,
2021
Net Sales
Americas
$170.5 $161.9 
EMEA
41.2 50.2 
Asia Pacific
22.9 20.7 
Total
$234.6 $232.8 
Operating earnings as a percentage of net sales
25 %31 %

The following table presents the components of net sales change by geographic region for the Contractor segment:
Three Months
Volume and PriceAcquisitions CurrencyTotal
Americas5%0%0%5%
EMEA(17)%4%(5)%(18)%
Asia Pacific14%0%(3)%11%
Segment Total1%1%(1)%1%

Contractor segment sales increased modestly as continued stability in North American construction markets and improved demand in Asia Pacific offset weakness in EMEA due to product availability. Higher product costs, unfavorable product and channel mix and the adverse impacts of currency translation drove a 6 percentage point decrease in the operating margin rate.

Liquidity and Capital Resources

Net cash provided by operating activities of $31 million decreased $70 million from the comparable period last year, mostly driven by increased salary and incentive payments and inventory purchases to meet demand levels. Significant uses of cash in 2022 included share repurchases of $109 million, long-term debt payments of $75 million, property, plant and equipment additions of $47 million, dividend payments of $36 million, and $25 million to acquire businesses that were not material to the consolidated financial statements. Proceeds from shares issued in 2022 totaled $21 million.

Significant uses of cash in 2021 included dividend payments of $32 million, property, plant and equipment additions of $21 million partially offset by proceeds from shares issued of $26 million.
19


As of April 1, 2022, the Company had available liquidity of $908 million, including cash held in deposit accounts of $380 million, of which $152 million was held outside of the U.S., and available credit under existing committed credit facilities of $528 million.

Cash balances and unused financing sources are expected to provide the Company with the flexibility to meet its liquidity needs in 2022, including its capital expenditure plan, planned dividends, share repurchases, acquisitions and operating requirements. Capital expenditures for 2022 are expected to be approximately $190 million, including $140 million in facility expansion projects. The Company may make opportunistic share repurchases going forward.

Outlook

For the full-year 2022, the Company is targeting high single digit sales growth on an organic, constant currency basis. Underlying demand in key end markets and geographies remains solid, however, the Company is keeping a close eye on how economic and geopolitical conditions may impact the balance of the year, especially in EMEA. While the Company is starting the second quarter with a strong backlog, the Company’s backlog is not a good indicator of future long-term business levels. In addition to economic growth, the successful launch of new products and expanded distribution coverage, the sales outlook is dependent on many factors, including realization of price increases and stable foreign currency exchange rates.

Cautionary Statement Regarding Forward-Looking Statements

The Company desires to take advantage of the “safe harbor” provisions regarding forward-looking statements of the Private Securities Litigation Reform Act of 1995 and is filing this Cautionary Statement in order to do so. From time to time various forms filed by our Company with the Securities and Exchange Commission, including our Form 10-K, Form 10-Qs and Form 8-Ks, and other disclosures, including our 2021 Overview report, press releases, earnings releases, analyst briefings, conference calls and other written documents or oral statements released by our Company, may contain forward-looking statements. Forward-looking statements generally use words such as “expect,” “foresee,” “anticipate,” “believe,” “project,” “should,” “estimate,” “will,” and similar expressions, and reflect our Company’s expectations concerning the future. All forecasts and projections are forward-looking statements. Forward-looking statements are based upon currently available information, but various risks and uncertainties may cause our Company’s actual results to differ materially from those expressed in these statements. The Company undertakes no obligation to update these statements in light of new information or future events.

Future results could differ materially from those expressed due to the impact of changes in various factors. These risk factors include, but are not limited to: the impact of the COVID-19 pandemic on our business; Russia's invasion of Ukraine, and the sanctions and actions taken against Russia and Belarus in response to the invasion; economic conditions in the United States and other major world economies; our Company’s growth strategies, which include making acquisitions, investing in new products, expanding geographically and targeting new industries; changes in currency translation rates; the ability to meet our customers’ needs and changes in product demand; supply interruptions or delays; security breaches; new entrants who copy our products or infringe on our intellectual property; risks incident to conducting business internationally; catastrophic events; changes in laws and regulations; compliance with anti-corruption and trade laws; changes in tax rates or the adoption of new tax legislation; the possibility of asset impairments if acquired businesses do not meet performance expectations; political instability; results of and costs associated with litigation, administrative proceedings and regulatory reviews incident to our business; our ability to attract, develop and retain qualified personnel; the possibility of decline in purchases from a few large customers of the Contractor segment, variations in activity in the construction, automotive, mining and oil and natural gas industries, and the impact of declines in interest rates, asset values and investment returns on pension costs and required pension contributions. Please refer to Item 1A of our Annual Report on Form 10-K for fiscal year 2021 and Item 1A of this Form 10-Q for a more comprehensive discussion of these and other risk factors. These reports are available on the Company’s website at www.graco.com and the Securities and Exchange Commission’s website at www.sec.gov. Shareholders, potential investors and other readers are urged to consider these factors in evaluating forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements.

Investors should realize that factors other than those identified above and in Item 1A might prove important to the Company’s future results. It is not possible for management to identify each and every factor that may have an impact on the Company’s operations in the future as new factors can develop from time to time.


20

Item 3.Quantitative and Qualitative Disclosures About Market Risk

There have been no material changes related to market risk from the disclosures made in the Company’s 2021 Annual Report on Form 10-K.

Item 4.Controls and Procedures

Evaluation of disclosure controls and procedures

As of the end of the fiscal quarter covered by this report, the Company carried out an evaluation of the effectiveness of the design and operation of its disclosure controls and procedures. This evaluation was done under the supervision and with the participation of the Company’s President and Chief Executive Officer and the Chief Financial Officer and Treasurer. Based upon that evaluation, the Company's President and Chief Executive Officer and the Chief Financial Officer and Treasurer concluded that the Company’s disclosure controls and procedures are effective.

Changes in internal controls

During the quarter, there was no change in the Company’s internal control over financial reporting that has materially affected or is reasonably likely to materially affect the Company’s internal control over financial reporting.

PART IIOTHER INFORMATION

Item 1A.Risk Factors

Except as noted below, there have been no material changes to the Company’s risk factors from those disclosed in the Company’s 2021 Annual Report on Form 10-K.

Russian Invasion of Ukraine – Russia’s invasion of Ukraine, and the sanctions and actions taken against Russia and Belarus in response to the invasion, could adversely impact our business.

While our sales into Russia and Belarus are not material to our overall business, and we do not have any physical operations in Russia or Belarus or source raw materials or components directly from either country, the Russian invasion of Ukraine and the resulting sanctions and actions taken against Russia and Belarus by the United States, the United Kingdom, the European Union, Switzerland and others have considerably depressed demand for our products in Russia and Belarus and restricted our ability to sell certain products in those countries. As a result, we have decided to suspend sales into Russia and Belarus for the time being. We expect demand for our products in Russia and Belarus to remain depressed, and our ability to sell certain products in Russia and Belarus to continue to be restricted, for the foreseeable future. A significant escalation or expansion of the conflict beyond its current geographic, political and economic scope and scale could have a material adverse effect on our business, results of operations and financial condition, and could exacerbate other risks discussed in our 2021 Annual Report on Form 10-K. Such risks include, but are not limited to: an increase in the frequency and severity of the cybersecurity threats we and various third parties with whom we do business experience; unfavorable changes in exchange rates; further shortages, delivery delays and price inflation in a wide variety of raw materials and components; widespread reductions in end-user demand; and increased logistical challenges.
21

Item 2.Unregistered Sales of Equity Securities and Use of Proceeds

Issuer Purchases of Equity Securities

On April 24, 2015, the Board of Directors authorized the Company to purchase up to 18 million shares of its outstanding common stock, primarily through open-market transactions. There were approximately 3.3 million shares remaining under the authorization on December 7, 2018, when the Board of Directors authorized the purchase of up to an additional 18 million shares. The authorizations are for an indefinite period of time or until terminated by the Board.

In addition to shares purchased under the Board authorizations, the Company purchases shares of common stock held by employees who wish to tender owned shares to satisfy the exercise price or tax due upon exercise of options or vesting of restricted stock.

Information on issuer purchases of equity securities follows:
PeriodTotal Number
of Shares Purchased  
Average Price
Paid per Share
Total Number of Shares Purchased as Part of Publicly Announced Plans or ProgramsMaximum Number of Shares that May Yet Be
Purchased Under the Plans or Programs
(at end of period)
January 1, 2022 - January 28, 202217,200 $69.69 — 18,500,634 
January 29, 2022 - February 25, 20221,117,639 $71.44 — 17,382,995 
February 26, 2022 - April 1, 2022382,361 $71.37 — 17,000,634 


22

Item 6.Exhibits
3.1 
3.2 
Certification of President and Chief Executive Officer pursuant to Rule 13a-14(a).
Certification of Chief Financial Officer and Treasurer pursuant to Rule 13a-14(a).
Certification of President and Chief Executive Officer and Chief Financial Officer and Treasurer pursuant to Section 1350 of Title 18, U.S.C.
Press Release Reporting First Quarter Earnings dated April 27, 2022.
101 Interactive data files pursuant to Rule 405 of Regulation S-T formatted in iXBRL (Inline eXtensible Business Reporting Language).